Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy

PaperCitations, authors & open-access status

A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 77 citations, 2022 year and closed oa status.

77
Citations
2022
Year
closed
OA Status

Related on ScholarIQ

Lulu Zhou
Author
Nanoplatforms for cancer theranostics
Topic
Nanoplatforms for cancer theranostics
Topic
Ferroptosis and cancer prognosis
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account